Education
About Us
Working with TipRanks
Follow Us
Evotec AG (EVO)
NASDAQ:EVO
Earnings Data
Report Date
Apr 01, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.03Last Year’s EPS
-0.1Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflects a challenging environment for Evotec, with significant headwinds in the D&PD segment and overall revenue declines. However, the company showcases strong growth in the Biologics segment, transformational strategic partnerships, and effective cost reduction efforts. These positive developments, particularly the Sandoz deal and asset pipeline progression, suggest an optimistic outlook despite current challenges.Company Guidance
Just-Evotec Biologics Growth
The Just-Evotec Biologics segment showed a strong performance with revenues reaching EUR 143.2 million, up 11% compared to the previous year. Additionally, non-Sandoz and non-DoD customers grew by 105% in the first 9 months of the year.
Transformational Deal with Sandoz
Evotec signed a transformational deal with Sandoz, which is expected to unlock payments of more than $650 million over the next years. This includes a $350 million upfront payment and potential mid-term revenues exceeding $300 million.
Asset Pipeline Progression
Evotec's asset pipeline is progressing well, with the expectation of up to 4 molecules from their partnered asset pipeline to enter Phase II clinical studies in 2026.
Cost Reduction Initiatives
Evotec is ahead of its cost reduction plan, with a commitment to EUR 60 million of cost out in 2025 and working on delivering an additional EUR 50 million in cost out and productivity measures.
EVO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
EVO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $3.97 | $3.34 | -15.87% |
Aug 13, 2025 | $3.81 | $3.81 | 0.00% |
May 06, 2025 | $4.17 | $4.05 | -2.88% |
Apr 17, 2025 | $3.27 | $3.60 | +10.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Evotec AG (EVO) report earnings?
Evotec AG (EVO) is schdueled to report earning on Apr 01, 2026, TBA (Confirmed).
What is Evotec AG (EVO) earnings time?
Evotec AG (EVO) earnings time is at Apr 01, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EVO EPS forecast?
EVO EPS forecast for the fiscal quarter 2025 (Q4) is 0.03.